London, United Kingdom

Peter J Machin

This inventor holds 23 USPTO granted patents and 4 published patent applications and 2 EPO patents, primarily in Chemical Compounds. Top assignees: Hoffmann-La Roche Inc., Artax Biopharma Inc., Enyo Pharma. Active years: 1983-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter J Machin. Retrieved from https://idiyas.com/inventor/peter-j-machin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 214(Granted Patents)


Company Filing History:


Years Active: 1983-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Chromene Derivatives
NADPH Oxidase Inhibitors
Thiophene Derivatives
Amino Acid Derivatives
Phosphinic Acid Derivatives
Collagenase Inhibitors
Oxazole Derivatives
Anti-Arthritic Activity
Substituted Phenoxy-Aminopropanol
Fused Thiophene
Non-Fused Thiophene
Thiadiazole Derivatives
23 patents (USPTO):Explore Patents

Title: Pioneer of Innovation: The Visionary Inventor Peter J Machin

Introduction:

Peter J Machin, a distinguished inventor based in London, GB, is renowned for his passion for innovation and his unwavering commitment to excellence in the field of technology. With a remarkable portfolio of 21 patents, Machin has significantly contributed to the advancement of science and has become a leading figure in the global landscape of invention.

Latest Patents:

Among his latest patents, Machin has introduced groundbreaking inventions such as "Non-fused thiophene derivatives and their uses," which offer novel treatment options for a myriad of diseases including infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders, and inflammatory disorders. Additionally, his invention of "Chromene derivatives as inhibitors of TCR-Nck interaction" showcases his innovative approach towards developing compounds that modulate critical interactions within the human body.

Career Highlights:

Throughout his illustrious career, Peter J Machin has garnered recognition for his innovative contributions while working with esteemed companies such as Hoffmann-La Roche Inc. and Enyo Pharma. His relentless pursuit of excellence and his ability to translate cutting-edge research into practical solutions have set him apart as a visionary inventor in the industry.

Collaborations:

Machin's collaborative efforts with accomplished coworkers Balraj K Handa and Joseph A Martin have further enhanced the impact of his inventions. Together, they have engaged in pioneering research projects that have pushed the boundaries of innovation and have paved the way for future breakthroughs in technology and healthcare.

Conclusion:

In conclusion, Peter J Machin's remarkable journey as an inventor exemplifies his dedication to driving positive change through innovation. His contributions not only inspire the next generation of inventors but also continue to shape the future of technology. Machin's relentless pursuit of excellence and his visionary approach to invention ensure that his legacy as a trailblazer in the field will endure for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…